MICHAEL WHITE to Antineoplastic Agents
This is a "connection" page, showing publications MICHAEL WHITE has written about Antineoplastic Agents.
Connection Strength
0.752
-
Chemotherapy-Associated Hepatotoxicities. Surg Clin North Am. 2016 Apr; 96(2):207-17.
Score: 0.246
-
Mode of action and pharmacogenomic biomarkers for exceptional responders to didemnin B. Nat Chem Biol. 2015 Jun; 11(6):401-8.
Score: 0.232
-
Stranger Things: New Roles and Opportunities for Androgen Receptor in Oncology Beyond Prostate Cancer. Endocrinology. 2023 04 17; 164(6).
Score: 0.101
-
Heterogeneity in PD-L1 expression in malignant peritoneal mesothelioma with systemic or intraperitoneal chemotherapy. Br J Cancer. 2021 02; 124(3):564-566.
Score: 0.085
-
Selective Cytotoxicity of the NAMPT Inhibitor FK866 Toward Gastric Cancer Cells With Markers of the Epithelial-Mesenchymal Transition, Due to Loss of NAPRT. Gastroenterology. 2018 09; 155(3):799-814.e13.
Score: 0.073
-
Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets. Nat Commun. 2015 Apr 09; 6:6744.
Score: 0.014